Marion Smits
Erasmus Universiteit Rotterdam
H-index: 65
Europe-Netherlands
Top articles of Marion Smits
Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open …
EBioMedicine
2024/4/1
Marion Smits
H-Index: 40
[18F] FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors
Journal of Nuclear Medicine
2024/3/21
Marion Smits
H-Index: 40
Advanced Imaging in the Diagnosis and Response Assessment of High-Grade Glioma: AJR Expert Panel Narrative Review
2024/3/13
Marion Smits
H-Index: 40
Linda Knutsson
H-Index: 21
Diagnóstico prequirúrgico de gliomas difusos en adultos: perspectivas prácticas de radiólogos de Unidades de neurooncología Post-WHO 2021
Radiología
2024/3/12
Challenges, Limitations and Pitfalls of PET and Advanced MRI in Patients with Brain Tumors-A Report of the PET/RANO Group
2024/3/11
Marion Smits
H-Index: 40
The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen
Cancer research
2024/3/1
Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery …
European Radiology
2024/1/29
Esther Warnert
H-Index: 6
Marion Smits
H-Index: 40
Probing the glioma microvasculature: a case series of the comparison between perfusion MRI and intraoperative high-frame-rate ultrafast Doppler ultrasound
European Radiology Experimental
2024/1/26
Pieter Kruizinga
H-Index: 14
Marion Smits
H-Index: 40
Translating radiological research into practice—from discovery to clinical impact
Insights into imaging
2024/1/17
Marion Smits
H-Index: 40
Francesco Sardanelli
H-Index: 41
Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide
Neuro-oncology
2024/1/14
Marion Smits
H-Index: 40
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
2024/1/1
Improved reliability of perfusion estimation in dynamic susceptibility contrast MRI by using the arterial input function from dynamic contrast enhanced MRI
NMR in Biomedicine
2024/1
Marion Smits
H-Index: 40
MR Vascular Fingerprinting with Hybrid Gradient–Spin Echo Dynamic Susceptibility Contrast MRI for Characterization of Microvasculature in Gliomas
Cancers
2023/4/6
Marion Smits
H-Index: 40
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
2023/11/1
Microvasculature Features Derived from Hybrid EPI MRI in Non-Enhancing Adult-Type Diffuse Glioma Subtypes
Cancers
2023/4/4
Marion Smits
H-Index: 40
Arterial spin labelling MRI for brain tumour surveillance: do we really need cerebral blood flow maps?
European Radiology
2023/11
Anouk Van Der Hoorn
H-Index: 13
Marion Smits
H-Index: 40
IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas
Neuro-oncology
2023/4/1
Pim B Van Der Meer
H-Index: 3
Marion Smits
H-Index: 40
Dynamic-susceptibility-contrast perfusion-weighted-imaging (DSC-PWI) in brain tumors: a brief up-to-date overview for clinical neuroradiologists
Plos one
2023/7/14
Primary brain tumours in adults
2023/10/28
Marion Smits
H-Index: 40
Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study
Neuro-oncology
2023/3/1
